Related Experiment Video
Updated: Jun 12, 2026
16:40
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Cardiovascular implantable electronic devices in athletes
1Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
Cardiovascular Therapeutics
|June 18, 2010
Summary
Managing cardiovascular implantable electronic devices (CIEDs) in athletes presents unique challenges. This review covers CIED therapy, sudden cardiac death, and physical activity guidelines for this growing patient group.
Area of Science:
- Cardiology
- Biomedical Engineering
- Sports Medicine
Background:
- Cardiovascular implantable electronic device (CIED) use, including pacemakers and implantable cardiac defibrillators, is increasing, even among athletes.
- Managing CIEDs in athletes is complex due to increased physical demands, longer device exposure in younger individuals, and variable cardiac conditions.
Purpose of the Study:
- To review management complexities of CIEDs in athletes.
- To discuss sudden cardiac death risks and prevention in this population.
- To provide consensus recommendations for physical activity with CIEDs.
Main Methods:
- Literature review of CIED management in athletic populations.
- Analysis of factors contributing to management complexity.
- Synthesis of current guidelines on physical activity and CIEDs.
Main Results:
- CIED management in athletes requires consideration of unique physiological and demographic factors.
- Sudden cardiac death remains a critical concern, necessitating tailored risk assessment.
- Evidence-based recommendations for safe physical activity are crucial for athletes with CIEDs.
Conclusions:
- Athletes with CIEDs require specialized management strategies.
- Optimizing CIED therapy involves balancing device function with athletic performance and safety.
- Clear guidelines are needed to support athletes with CIEDs in pursuing physical activity.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:20Exercise and Cardiovascular Response
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...